SEC Form 4 · accession 0001209191-16-151318
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas F Kearns Jr.
Director
Period of report
Nov 17, 2016
Accepted (ET)
Nov 18, 2016 · 7:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 17, 2016 | M | 5,000 | $4.025 | A | 165,564 | D | |
| Common StockF1 | Nov 17, 2016 | S | 5,000 | $22.2056 | D | 160,564 | D | |
| Common Stock | Nov 18, 2016 | M | 13,000 | $4.025 | A | 173,564 | D | |
| Common StockF2 | Nov 18, 2016 | S | 13,000 | $22.4717 | D | 160,564 | D | |
| Common Stock | holding | — | — | — | 110,000 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $4.025 | Nov 17, 2016 | M | 5,000 | D | — | Aug 19, 2017 | Common Stock | 5,000 | 7,000 | D |
| Stock Option (Right to Buy)F3 | $4.025 | Nov 18, 2016 | M | 7,000 | D | — | Aug 19, 2017 | Common Stock | 7,000 | 0 | D |
| Stock Option (Right to Buy)F3 | $4.025 | Nov 18, 2016 | M | 6,000 | D | — | Aug 19, 2017 | Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1The shares were sold at prices ranging from $22.10 to $22.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2The shares were sold at prices ranging from $22.35 to $22.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Fully vested.